We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Workhorse Group Inc | NASDAQ:WKHS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0071 | -3.40% | 0.2016 | 0.2002 | 0.2083 | 200,061 | 13:12:08 |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Nevada | 26-1394771 | |||||||
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Common Stock, $0.001 par value per share | WKHS | The NASDAQ Capital Market |
Condensed Consolidated Statements of Comprehensive Loss | ||||||||
June 30,
2021 |
December 31,
2020 |
||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 156,610,794 | $ | 46,817,825 | |||||||
Restricted cash held in escrow | — | 194,411,242 | |||||||||
Investment in LMC | 182,251,126 | — | |||||||||
Accounts and lease receivable, less allowance for credit losses of zero at June 30, 2021 and December 31, 2020, respectively
|
1,954,609 | 1,132,164 | |||||||||
Inventory, net | 49,505,118 | 15,467,012 | |||||||||
Prepaid expenses | 40,259,135 | 32,759,216 | |||||||||
Total current assets | 430,580,782 | 290,587,459 | |||||||||
Property, plant and equipment, net
|
13,891,532 | 11,398,166 | |||||||||
Investment in LMC | — | 330,556,744 | |||||||||
Total Assets | $ | 444,472,314 | $ | 632,542,369 | |||||||
Liabilities | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 7,542,280 | $ | 4,790,763 | |||||||
Accrued liabilities | 5,195,889 | 5,995,302 | |||||||||
Warranty liability | 4,866,213 | 5,400,000 | |||||||||
PPP Term Note | — | 1,411,000 | |||||||||
Total current liabilities | 17,604,382 | 17,597,065 | |||||||||
Other long-term liabilities | 207,040 | 207,040 | |||||||||
Deferred tax liability | 2,919,491 | 21,833,930 | |||||||||
Convertible notes, at fair value | 200,900,000 | 197,700,000 | |||||||||
Total Liabilities | 221,630,913 | 237,338,035 | |||||||||
Commitments and contingencies | |||||||||||
Stockholders’ Equity: | |||||||||||
Series A preferred stock, par value $0.001 per share, 75,000,000 shares authorized,
zero shares issued and outstanding as of June 30, 2021 and December 31, 2020
|
— | — | |||||||||
Common stock, par value $0.001 per share, 250,000,000 shares authorized, 123,414,045
shares issued and outstanding as of June 30, 2021 and 121,922,532 shares issued and
outstanding as of December 31, 2020
|
123,414 | 121,923 | |||||||||
Additional paid-in capital | 506,073,876 | 504,112,442 | |||||||||
Accumulated deficit | (273,155,889) | (109,030,031) | |||||||||
Accumulated other comprehensive loss | (10,200,000) | — | |||||||||
Total stockholders’ equity | 222,841,401 | 395,204,334 | |||||||||
Total Liabilities and Stockholders’ Equity | $ | 444,472,314 | $ | 632,542,369 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||||||||||
Net sales | $ | 1,202,876 | $ | 91,942 | $ | 1,723,936 | $ | 176,242 | |||||||||||||||||||||||||||||||||||||||
Cost of sales | 14,796,130 | 1,511,360 | 21,021,429 | 3,259,335 | |||||||||||||||||||||||||||||||||||||||||||
Gross loss | (13,593,254) | (1,419,418) | (19,297,493) | (3,083,093) | |||||||||||||||||||||||||||||||||||||||||||
Operating expenses | |||||||||||||||||||||||||||||||||||||||||||||||
Selling, general and administrative | 7,005,537 | 3,949,081 | 13,891,367 | 9,514,868 | |||||||||||||||||||||||||||||||||||||||||||
Research and development | 2,123,860 | 1,616,604 | 5,987,575 | 3,518,840 | |||||||||||||||||||||||||||||||||||||||||||
Total operating expenses | 9,129,397 | 5,565,685 | 19,878,942 | 13,033,708 | |||||||||||||||||||||||||||||||||||||||||||
Other (loss) income | (11,699,666) | — | (148,305,618) | 864,900 | |||||||||||||||||||||||||||||||||||||||||||
Loss from operations | (34,422,317) | (6,985,103) | (187,482,053) | (15,251,901) | |||||||||||||||||||||||||||||||||||||||||||
Interest expense (income), net | 10,478,717 | 124,346,806 | (4,441,756) | 111,323,317 | |||||||||||||||||||||||||||||||||||||||||||
Loss before benefit for income taxes | (44,901,034) | (131,331,909) | (183,040,297) | (126,575,218) | |||||||||||||||||||||||||||||||||||||||||||
Benefit for income taxes | (1,281,947) | — | (18,914,439) | — | |||||||||||||||||||||||||||||||||||||||||||
Net loss | $ | (43,619,087) | $ | (131,331,909) | $ | (164,125,858) | $ | (126,575,218) | |||||||||||||||||||||||||||||||||||||||
Net loss per share of common stock - basic and diluted | $ | (0.35) | $ | (1.76) | $ | (1.33) | $ | (1.77) | |||||||||||||||||||||||||||||||||||||||
Weighted average number of common shares outstanding - basic and diluted | 123,414,045 | 74,701,343 | 122,984,218 | 71,583,551 | |||||||||||||||||||||||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||
Net loss | $ | (43,619,087) | $ | (131,331,909) | $ | (164,125,858) | $ | (126,575,218) | |||||||||||||||||||||||||||
Other comprehensive (loss) income | |||||||||||||||||||||||||||||||||||
Change in fair value of convertible notes attributable to credit risk | (10,200,000) | — | (10,200,000) | 1,100,000 | |||||||||||||||||||||||||||||||
Comprehensive loss | $ | (53,819,087) | $ | (131,331,909) | $ | (174,325,858) | $ | (125,475,218) |
Common Stock |
Series A
Preferred Stock |
Additional
Paid-in Capital |
Accumulated
Deficit |
Accumulated Other Comprehensive Income |
Total
Stockholders’ Deficit |
||||||||||||||||||||||||||||||||||||||||||
Number
of Shares |
Amount |
Number
of Shares |
Amount | ||||||||||||||||||||||||||||||||||||||||||||
Balance as of March 31, 2020 | 69,493,836 | $ | 69,494 | — | $ | — | $ | 150,883,717 | $ | (174,049,839) | $ | 1,100,000 | $ | (21,996,628) | |||||||||||||||||||||||||||||||||
Stock options and warrants exercised, and vesting of restricted shares | 12,479,122 | 12,479 | — | — | 46,902,920 | — | — | 46,915,399 | |||||||||||||||||||||||||||||||||||||||
Common stock issued for preferred stock dividends | 308,642 | 309 | — | — | 499,691 | — | — | 500,000 | |||||||||||||||||||||||||||||||||||||||
Conversion of convertible notes | 6,837,381 | 6,837 | — | — | 33,534,630 | — | — | 33,541,467 | |||||||||||||||||||||||||||||||||||||||
Common stock issued for interest on convertible notes | 211,142 | 211 | — | — | 724,474 | — | — | 724,685 | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 1,170,191 | — | — | 1,170,191 | |||||||||||||||||||||||||||||||||||||||
Net loss for the three months ended June 30, 2020 | — | — | — | — | — | (131,331,909) | — | (131,331,909) | |||||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Balance as of June 30, 2020 | 89,330,123 | $ | 89,330 | — | $ | — | $ | 233,715,623 | $ | (305,381,748) | $ | 1,100,000 | $ | (70,476,795) |
Common Stock |
Series A
Preferred Stock |
Additional
Paid-in Capital |
Accumulated
Deficit |
Accumulated Other Comprehensive Income |
Total
Stockholders’ Deficit |
||||||||||||||||||||||||||||||||||||||||||
Number
of Shares |
Amount |
Number
of Shares |
Amount | ||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2019 | 67,105,000 | $ | 67,105 | — | $ | — | $ | 143,826,315 | $ | (178,806,530) | $ | — | $ | (34,913,110) | |||||||||||||||||||||||||||||||||
Stock options and warrants exercised, and vesting of restricted shares | 12,911,234 | 12,911 | — | — | 47,145,488 | — | — | 47,158,399 | |||||||||||||||||||||||||||||||||||||||
Common stock issued for preferred stock dividends | 617,284 | 618 | — | — | 999,382 | — | — | 1,000,000 | |||||||||||||||||||||||||||||||||||||||
Conversion of convertible notes | 8,384,270 | 8,384 | — | — | 38,726,635 | — | — | 38,735,019 | |||||||||||||||||||||||||||||||||||||||
Common stock issued for interest on convertible notes | 312,335 | 312 | — | — | 988,585 | — | — | 988,897 | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 2,029,218 | — | — | 2,029,218 | |||||||||||||||||||||||||||||||||||||||
Net loss for the six months ended June 30, 2020 | — | — | — | — | — | (126,575,218) | — | (126,575,218) | |||||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | 1,100,000 | 1,100,000 | |||||||||||||||||||||||||||||||||||||||
Balance as of June 30, 2020 | 89,330,123 | $ | 89,330 | — | $ | — | $ | 233,715,623 | $ | (305,381,748) | $ | 1,100,000 | $ | (70,476,795) |
Common Stock |
Series A
Preferred Stock |
Additional
Paid-in Capital |
Accumulated
Deficit |
Accumulated Other Comprehensive Loss |
Total
Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||
Number
of Shares |
Amount |
Number
of Shares |
Amount | ||||||||||||||||||||||||||||||||||||||||||||
Balance as of March 31, 2021 | 123,254,853 | $ | 123,255 | — | $ | — | $ | 505,017,758 | $ | (229,536,802) | $ | — | $ | 275,604,211 | |||||||||||||||||||||||||||||||||
Stock options and warrants exercised, and vesting of restricted shares | 159,192 | 159 | — | — | (83,795) | — | — | (83,636) | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 1,139,913 | — | — | 1,139,913 | |||||||||||||||||||||||||||||||||||||||
Net loss for the three months ended June 30, 2021 | — | — | — | — | — | (43,619,087) | — | (43,619,087) | |||||||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | (10,200,000) | (10,200,000) | |||||||||||||||||||||||||||||||||||||||
Balance as of June 30, 2021 | 123,414,045 | $ | 123,414 | — | $ | — | $ | 506,073,876 | $ | (273,155,889) | $ | (10,200,000) | $ | 222,841,401 |
Common Stock |
Series A
Preferred Stock |
Additional
Paid-in Capital |
Accumulated
Deficit |
Accumulated Other Comprehensive Loss |
Total
Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||
Number
of Shares |
Amount |
Number
of Shares |
Amount | ||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2020 | 121,922,532 | $ | 121,923 | — | $ | — | $ | 504,112,442 | $ | (109,030,031) | $ | — | $ | 395,204,334 | |||||||||||||||||||||||||||||||||
Stock options and warrants exercised, and vesting of restricted shares | 1,491,513 | 1,491 | — | — | (70,907) | — | — | (69,416) | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 2,032,341 | — | — | 2,032,341 | |||||||||||||||||||||||||||||||||||||||
Net loss for the six months ended June 30, 2021 | — | — | — | — | — | (164,125,858) | — | (164,125,858) | |||||||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | (10,200,000) | (10,200,000) | |||||||||||||||||||||||||||||||||||||||
Balance as of June 30, 2021 | 123,414,045 | $ | 123,414 | — | $ | — | $ | 506,073,876 | $ | (273,155,889) | $ | (10,200,000) | $ | 222,841,401 |
Six Months Ended June 30, | |||||||||||
2021 | 2020 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net loss | $ | (164,125,858) | $ | (126,575,218) | |||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
Depreciation | 787,846 | 368,372 | |||||||||
Tooling expense | — | 353,786 | |||||||||
Amortization of discount on mandatorily redeemable Series B preferred stock | — | 762,614 | |||||||||
Change in fair value of convertible notes and loss on conversion to common stock | (7,000,000) | 96,145,019 | |||||||||
Change in fair value of warrant liability | — | 12,176,690 | |||||||||
Change in fair value of investment in LMC | 148,305,618 | (864,900) | |||||||||
Dividends for mandatorily redeemable Series B preferred stock paid in common stock | — | 1,000,000 | |||||||||
Interest on convertible notes paid in common stock | — | 988,897 | |||||||||
Stock-based compensation | 2,032,341 | 2,029,218 | |||||||||
Write down of inventory | (7,560,774) | — | |||||||||
Forgiveness of PPP Term Note | (1,411,000) | — | |||||||||
Deferred taxes | (18,914,439) | — | |||||||||
Effects of changes in operating assets and liabilities: | |||||||||||
Accounts and lease receivable | (822,445) | (15,348) | |||||||||
Inventory | (26,477,331) | (2,378,143) | |||||||||
Prepaid expenses | (7,499,919) | 59,882 | |||||||||
Accounts payable and accrued liabilities | 1,952,104 | 117,047 | |||||||||
Warranty liability | (533,787) | (1,922,095) | |||||||||
Net cash used in operating activities | (81,267,644) | (17,754,179) | |||||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures | (3,281,213) | (974,115) | |||||||||
Net cash used in investing activities | (3,281,213) | (974,115) | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from PPP Term Note | — | 1,411,000 | |||||||||
Exercise of warrants and options and restricted share award activity | (69,416) | 18,646,709 | |||||||||
Net cash (used in) provided by financing activities | (69,416) | 20,057,709 | |||||||||
Change in cash and cash equivalents | (84,618,273) | 1,329,415 | |||||||||
Cash, cash equivalents and restricted cash, beginning of the period | 241,229,067 | 24,868,416 | |||||||||
Cash and cash equivalents, end of the period | $ | 156,610,794 | $ | 26,197,831 |
June 30, 2021 | December 31, 2020 | ||||||||||
Raw materials | $ | 44,283,636 | $ | 16,759,232 | |||||||
Work in process | 6,296,029 | 422,176 | |||||||||
Finished goods | 8,478,042 | 277,419 | |||||||||
59,057,707 | 17,458,827 | ||||||||||
Less: inventory reserve | (9,552,589) | (1,991,815) | |||||||||
Inventory, net | $ | 49,505,118 | $ | 15,467,012 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
Automotive | $ | 1,120,000 | $ | 85,000 | $ | 1,615,000 | $ | 85,000 | |||||||||||||||
Aviation | — | — | 22,400 | 60,783 | |||||||||||||||||||
Other | 82,876 | 6,942 | 86,536 | 30,459 | |||||||||||||||||||
Total revenues | $ | 1,202,876 | $ | 91,942 | $ | 1,723,936 | $ | 176,242 |
June 30, 2021 | ||||||||
Balance, December 31, 2020 | $ | 197,700,000 | ||||||
Change in fair value (1) | (15,500,000) | |||||||
Change in fair value attributable to credit risk (2) | — | |||||||
Balance, March 31, 2021 | 182,200,000 | |||||||
Change in fair value (1) | 8,500,000 | |||||||
Change in fair value attributable to credit risk (2) | 10,200,000 | |||||||
Balance, June 30, 2021 | $ | 200,900,000 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||
Stock options | $ | 21,210 | $ | 347,328 | $ | 91,622 | $ | 427,758 | |||||||||||||||||||||||||||
Restricted stock | 1,118,703 | 822,863 | 1,940,719 | 1,601,460 | |||||||||||||||||||||||||||||||
Total stock-based compensation | $ | 1,139,913 | $ | 1,170,191 | $ | 2,032,341 | $ | 2,029,218 |
Number of Options |
Weighted
Average Exercise Price per Option |
Weighted
Average Grant Date Fair Value per Option |
Weighted
Average Remaining Contractual Life (Years) |
|||||||||||||||||||||||
Balance, December 31, 2020 | 2,351,240 | $ | 2.00 | 5.5 | ||||||||||||||||||||||
Granted | — | — | — | |||||||||||||||||||||||
Exercised | (770,677) | 3.11 | ||||||||||||||||||||||||
Forfeited | — | — | ||||||||||||||||||||||||
Expired | (29,000) | 4.99 | ||||||||||||||||||||||||
Balance, June 30, 2021 | 1,551,563 | $ | 1.40 | 5.6 | ||||||||||||||||||||||
Number of options exercisable at June 30, 2021 | 1,280,688 | $ | 1.43 | 6.2 |
Number of Unvested Shares | Weighted Average Grant Date Fair Value per Share | |||||||||||||
Balance, December 31, 2020 | 1,377,889 | $ | 2.70 | |||||||||||
Granted | 304,164 | 14.57 | ||||||||||||
Vested | (444,843) | 2.75 | ||||||||||||
Forfeited | — | — | ||||||||||||
Balance, June 30, 2021 | 1,237,210 | $ | 5.64 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
Stock-based awards and warrants | 3,827,804 | 24,294,118 | 3,827,804 | 24,294,118 | |||||||||||||||||||
Convertible notes | 5,667,328 | 9,958,506 | 5,667,328 | 12,488,899 |
June 30, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||||
Fair Value | Level 1 | Level 2 | Level 3 | Fair Value | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||||||||
Investment in LMC | $ | 182,251,126 | $ | 182,251,126 | $ | — | $ | — | $ | 330,556,744 | $ | 330,556,744 | $ | — | $ | — | |||||||||||||||||||||||||||||||
Total assets at fair value | $ | 182,251,126 | $ | 182,251,126 | $ | — | $ | — | $ | 330,556,744 | $ | 330,556,744 | $ | — | $ | — | |||||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||
Convertible notes | $ | 200,900,000 | $ | — | $ | — | $ | 200,900,000 | $ | 197,700,000 | $ | — | $ | — | $ | 197,700,000 | |||||||||||||||||||||||||||||||
Total liabilities at fair value | $ | 200,900,000 | $ | — | $ | — | $ | 200,900,000 | $ | 197,700,000 | $ | — | $ | — | $ | 197,700,000 |
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||||||||||||||
2021
|
2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||
Net sales | $ | 1,202,876 | $ | 91,942 | $ | 1,723,936 | $ | 176,242 | |||||||||||||||||||||||||||
Cost of sales | 14,796,130 | 1,511,360 | 21,021,429 | 3,259,335 | |||||||||||||||||||||||||||||||
Gross loss | (13,593,254) | (1,419,418) | (19,297,493) | (3,083,093) | |||||||||||||||||||||||||||||||
Operating expenses | |||||||||||||||||||||||||||||||||||
Selling, general and administrative | 7,005,537 | 3,949,081 | 13,891,367 | 9,514,868 | |||||||||||||||||||||||||||||||
Research and development | 2,123,860 | 1,616,604 | 5,987,575 | 3,518,840 | |||||||||||||||||||||||||||||||
Total operating expenses | 9,129,397 | 5,565,685 | 19,878,942 | 13,033,708 | |||||||||||||||||||||||||||||||
Other (loss) income | (11,699,666) | — | (148,305,618) | 864,900 | |||||||||||||||||||||||||||||||
Loss from operations | (34,422,317) | (6,985,103) | (187,482,053) | (15,251,901) | |||||||||||||||||||||||||||||||
Interest expense (income), net | 10,478,717 | 124,346,806 | (4,441,756) | 111,323,317 | |||||||||||||||||||||||||||||||
Loss before benefit for income taxes | (44,901,034) | (131,331,909) | (183,040,297) | (126,575,218) | |||||||||||||||||||||||||||||||
Benefit for income taxes | (1,281,947) | — | (18,914,439) | — | |||||||||||||||||||||||||||||||
Net loss | $ | (43,619,087) | $ | (131,331,909) | $ | (164,125,858) | $ | (126,575,218) |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||
2021
|
2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||
Change in fair value of convertible notes and loss on conversion to common stock | $ | 8,500,000 | $ | 101,343,165 | $ | (7,000,000) | $ | 96,206,717 | |||||||||||||||||||||||||||
Gain on forgiveness of PPP Term Note | — | — | (1,411,000) | — | |||||||||||||||||||||||||||||||
Contractual interest expense | 1,977,777 | 1,031,737 | 3,977,777 | 1,954,575 | |||||||||||||||||||||||||||||||
Change in fair value of warrant liability and loss on exercise of warrants | — | 21,321,690 | — | 12,176,690 | |||||||||||||||||||||||||||||||
Amortization of discount and debt issuance costs | — | 385,031 | — | 762,615 | |||||||||||||||||||||||||||||||
Other | 940 | 265,183 | (8,533) | 222,720 | |||||||||||||||||||||||||||||||
Total interest (income) expense, net | $ | 10,478,717 | $ | 124,346,806 | $ | (4,441,756) | $ | 111,323,317 |
Six Months Ended June 30, | |||||||||||
2021 | 2020 | ||||||||||
Net cash used in operating activities | $ | (81,267,644) | $ | (17,754,179) | |||||||
Net cash used in investing activities | $ | (3,281,213) | $ | (974,115) | |||||||
Net cash (used in) provided by financing activities | $ | (69,416) | $ | 20,057,709 |
Exhibit No. | Description | |||||||
10.1 | ||||||||
10.2 | ||||||||
31.1* | ||||||||
31.2* | ||||||||
32.1* | ||||||||
32.2* | ||||||||
101.INS | Inline XBRL INSTANCE DOCUMENT | |||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document | |||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
104 | Inline XBRL Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
WORKHORSE GROUP INC. | ||||||||
Dated: August 9, 2021 | By: | /s/ Richard Dauch | ||||||
Name: Richard Dauch
Title: Chief Executive Officer (Principal Executive Officer) |
Dated: August 9, 2021 | By: | /s/ Steve Schrader | ||||||
Name: Steve Schrader
Title: Chief Financial Officer (Principal Financial Officer) |
Dated: August 9, 2021 | By: | /s/ Gregory T. Ackerson | ||||||
Name: Gregory T. Ackerson
Title: Corporate Controller (Principal Accounting Officer) |
1 Year Workhorse Chart |
1 Month Workhorse Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions